Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David C Jackson

Showing results (61-70 of 118) with videos related to

Pageof 12
Sort By:
Vaccine|May 6, 2008
A self-adjuvanting lipopeptide-based vaccine candidate for the treatment of hepatitis C virus infectionBrendon Y Chua, Emily M Eriksson, Lorena E Brown, et al.
Immunology and Cell Biology|January 8, 2014
The use of a TLR2 agonist-based adjuvant for enhancing effector and memory CD8 T-cell responsesBrendon Y Chua, Matthew R Olson, Sammy Bedoui, et al.
Plos One|October 24, 2012
Hepatitis C VLPs delivered to dendritic cells by a TLR2 targeting lipopeptide results in enhanced antibody and cell-mediated responsesBrendon Y Chua, Douglas Johnson, Amabel Tan, et al.
Immunology and Cell Biology|April 23, 2016
Competition within the virus-specific CD4 T-cell pool limits the T follicular helper response after influenza infectionMatthew R Olson, Brendon Y Chua, Kim L Good-Jacobson, et al.
Molecular Pharmaceutics|July 25, 2012
Intranasal administration of the TLR2 agonist Pam2Cys provides rapid protection against influenza in miceAmabel C L Tan, Edin J Mifsud, Weiguang Zeng, et al.
Brain, Behavior, and Immunity|August 1, 2021
The endogenous inflammatory reflex inhibits the inflammatory response to different immune challenges in miceAlessandra Occhinegro, Chinn Yi Wong, Brendon Y Chua, et al.
Vaccine|May 29, 2012
A totally synthetic lipopeptide-based self-adjuvanting vaccine induces neutralizing antibodies against heat-stable enterotoxin from enterotoxigenic Escherichia coliWeiguang Zeng, Kristy Azzopardi, Dianna Hocking, et al.
Antiviral Research|April 17, 2012
Polyfunctional CD8(+) T cells are associated with the vaccination-induced control of a novel recombinant influenza virus expressing an HCV epitopeAmabel C L Tan, Emily M Y Eriksson, Katherine Kedzierska, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|December 11, 2012
Impaired dendritic cell maturation in response to pandemic H1N109 influenza virusRuth Chin, Linda Earnest-Silviera, Claire L Gordon, et al.
International Journal for Parasitology. Drugs and Drug Resistance|November 6, 2018
The Toll-Like Receptor 2 agonist PEG-Pam<sub>2</sub>Cys as an immunochemoprophylactic and immunochemotherapeutic against the liver and transmission stages of malaria parasitesMedard Ernest, Carol Hunja, Yuka Arakura, et al.
Pageof 12

Showing results (61-70 of 118) with videos related to

Sort By:
Pageof 12
Vaccine|May 6, 2008
A self-adjuvanting lipopeptide-based vaccine candidate for the treatment of hepatitis C virus infectionBrendon Y Chua, Emily M Eriksson, Lorena E Brown, et al.
Immunology and Cell Biology|January 8, 2014
The use of a TLR2 agonist-based adjuvant for enhancing effector and memory CD8 T-cell responsesBrendon Y Chua, Matthew R Olson, Sammy Bedoui, et al.
Plos One|October 24, 2012
Hepatitis C VLPs delivered to dendritic cells by a TLR2 targeting lipopeptide results in enhanced antibody and cell-mediated responsesBrendon Y Chua, Douglas Johnson, Amabel Tan, et al.
Immunology and Cell Biology|April 23, 2016
Competition within the virus-specific CD4 T-cell pool limits the T follicular helper response after influenza infectionMatthew R Olson, Brendon Y Chua, Kim L Good-Jacobson, et al.
Molecular Pharmaceutics|July 25, 2012
Intranasal administration of the TLR2 agonist Pam2Cys provides rapid protection against influenza in miceAmabel C L Tan, Edin J Mifsud, Weiguang Zeng, et al.
Brain, Behavior, and Immunity|August 1, 2021
The endogenous inflammatory reflex inhibits the inflammatory response to different immune challenges in miceAlessandra Occhinegro, Chinn Yi Wong, Brendon Y Chua, et al.
Vaccine|May 29, 2012
A totally synthetic lipopeptide-based self-adjuvanting vaccine induces neutralizing antibodies against heat-stable enterotoxin from enterotoxigenic Escherichia coliWeiguang Zeng, Kristy Azzopardi, Dianna Hocking, et al.
Antiviral Research|April 17, 2012
Polyfunctional CD8(+) T cells are associated with the vaccination-induced control of a novel recombinant influenza virus expressing an HCV epitopeAmabel C L Tan, Emily M Y Eriksson, Katherine Kedzierska, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|December 11, 2012
Impaired dendritic cell maturation in response to pandemic H1N109 influenza virusRuth Chin, Linda Earnest-Silviera, Claire L Gordon, et al.
International Journal for Parasitology. Drugs and Drug Resistance|November 6, 2018
The Toll-Like Receptor 2 agonist PEG-Pam<sub>2</sub>Cys as an immunochemoprophylactic and immunochemotherapeutic against the liver and transmission stages of malaria parasitesMedard Ernest, Carol Hunja, Yuka Arakura, et al.
Pageof 12